Litigation Details for Pfizer Inc. v. Glenmark Pharmaceuticals Limited (D. Del. 2019)
✉ Email this page to a colleague
Pfizer Inc. v. Glenmark Pharmaceuticals Limited (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-06-26 |
| Court | District Court, D. Delaware | Date Terminated | 2022-11-23 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Defendant | Referred To | |
| Patents | 8,791,140 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pfizer Inc. v. Glenmark Pharmaceuticals Limited
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Pfizer Inc. v. Glenmark Pharmaceuticals Limited (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-06-26 | 1 | Complaint | prior to the expiration of U.S. Patent No. 8,791,140 (“the ’140 patent”). Case 1:19-cv-01209-RGA Document… CLAIM FOR RELIEF – INFRINGEMENT OF U.S. PATENT NO. 8,791,140 36. Pfizer incorporates each… 1. This is an action for patent infringement under the patent laws of the United States, Title… Pfizer’s patents in the event that Glenmark’s ANDA Product is approved before the patents expire. …the United States Patent and Trademark Office (“PTO”) on July 29, 2014. The ’140 patent is listed in the | External link to document |
| 2019-09-03 | 15 | Redacted Document | prior to the expiration of U.S. Patent No. 8,791,140 (“the ’140 patent”). Case 1:19-cv-01209-RGA Document…action for infringement of U.S. Patent No. 8,791,140 (“the 140 patent”). Glenmark further admits that… published by FDA, listed U.S. Patent No. 8,791,140 (“the 140 patent”), inter alia, in connection with… 1. This is an action for patent infringement under the patent laws of the United States, Title…of Pfizer’s patents in the event that Glenmark’s ANDA Product is approved before the patents expire. | External link to document |
| 2022-11-22 | 194 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,140 B2. (Attachments: #… 23 November 2022 1:19-cv-01209 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| 2021-04-07 | 35 | Notice of Service | Initial Infringement Contentions for U.S. Patent No. 8,791,140 filed by PF PRISM C.V., PF Prism IMB B.V… 23 November 2022 1:19-cv-01209 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
